Search
Now showing items 1-1 of 1
Immunogenic cell death in cancer therapy
(Institute of Cancer Research (University Of London), 2024-01-16)
Triple negative breast cancer (TNBC) is a heterogenous disease which carries a poor prognosis, with the worst outcomes in the basal-like subtype. Despite the introduction of immunotherapy in the treatment paradigm the ...